Patient-preferred, as Consistently Demonstrated in Clinical Studies
Click on the Lead Author’s name for more information about each study.
Lead author |
Crinone 8% preferred versus other progesterone forms |
|
Fertil Steril, 2008 |
IM |
|
J Soc Gynecol Investig, 2000 |
IM, vaginal suppositories |
|
Hum Reprod, 2000 |
IM, vaginal suppositories |
|
Fertil Steril, 2007 |
Vaginal capsules |
|
Eur J Obstet Gynecol Reprod Biol, 2002 |
Vaginal capsules |
"[P]atients who had previously undergone the alternative treatment declared Crinone 8% to be a far more acceptable preparation . . . due to easier administration, more convenience, and less messiness in everyday use." – Simunic V, Fertil Steril, 20074 |
References: 1. Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein MD. Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial. Fertil Steril. 2008;89:485–487. 2. Levine H. Luteal support from the vaginal progesterone (P) gel Crinone 8%: preliminary results of multicenter trial show higher pregnancy rates than historical controls. J Soc Gynecol Investig. 2000;7(suppl). Abstract 571. 3. Schoolcraft WB, Hesla JS, Gee MJ. Experience with progesterone gel for luteal support in a highly successful IVF programme. Hum Reprod. 2000;15:1284–1288. 4. Simunic V, Tomic V, Tomic J, Nizic D. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support. Fertil Steril. 2007;87:83–87. 5. Ludwig M, Schwartz P, Babahan B, et al. Luteal phase support using either Crinone® 8% or Utrogest®: results of a prospective, randomized study. Eur J Obstet Gynecol Reprod Biol. 2002;103:48–52.